[The cytosolic concentrations of CAM26 and CAM29 in breast tumors classified according to the clinical stage].
Fernández
M
M
Suárez
B
B
González
C
C
Allende
M T
MT
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology; D003600:Cytosol / Q000276:immunology*; D005260:Female; D006801:Humans; D009077:Mucins / Q000032:analysis*; D009367:Neoplasm Staging
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D009077:Mucins; C057387:mucinous carcinoma-associated antigen
Estudio de las concentraciones citosólicas de CAM26 y CAM29 en tumores mamarios clasificados en función del estadio clínico.